Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vaxcyte Inc. Common Stock (PCVX) vs Park Hotels & Resorts Inc. Common Stock (PK) Price & Performance

Vaxcyte Inc. Common StockTrade
Park Hotels & Resorts Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Vaxcyte Inc. Common Stock vs Park Hotels & Resorts Inc. Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Park Hotels & Resorts Inc. Common Stock trades at $15.12 (market cap $3.14B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 3.3× Park Hotels & Resorts Inc. Common Stock's market cap, and Park Hotels & Resorts Inc. Common Stock pays a 6.41% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Park Hotels & Resorts Inc. Common Stock for 0 Days on average.

PCVXPK
Market Cap
$10.51B$3.14B
Volume
2,644,6943,553,985
Sector
HealthReal Estate
52-Week High
$73.82$16.17
52-Week Low
$40.32$9.84
Typical Hold Time
0 Days0 Days
Enterprise Value
$9.14B$6.98B
Dividend Yield
—6.41%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PCVX
100% Buy0% Sell
Avg holding period · 0 Days
PK
100% Buy0% Sell
Avg holding period · 0 Days

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →

About Park Hotels & Resorts Inc. Common Stock

Park Hotels & Resorts Inc. is a US lodging REIT, spun off from Hilton Worldwide in 2017, that owns a portfolio of premium-branded hotels and resorts in major urban, resort, and convention markets.

Read more on PK →